Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd
| Jurisdiction | Australia Federal only |
| Judge | French CJ.,Hayne J,Crennan,Kiefel JJ.,Gageler J. |
| Judgment Date | 04 December 2013 |
| Neutral Citation | 2013-1204 HCA A,[2013] HCA 50 |
| Docket Number | S219/2012 & S1/2013 |
| Court | High Court |
| Date | 04 December 2013 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
11 cases
-
InterPharma Pty Ltd v Hospira, Inc (No 5)
...Ltd v Sanofi-Aventis Australia Pty Ltd (No 2) [2012] FCAFC 102; 96 IPR 185; 204 FCR 494 Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50; 253 CLR 284 AstraZeneca AB v Apotex Pty Ltd [2014] FCAFC 99; 107 IPR 177; 226 FCR 324 AstraZeneca AB v Apotex Pty Ltd [2015] HCA 30; 257 C......
-
Minister for the Environment v Sharma
...v Ellis [2010] HCA 55; 240 CLR 111 Anns v Merton London Borough Council [1978] AC 728 Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50; 253 CLR 284 Australian Conservation Foundation Inc v Minister for the Environment and Energy [2017] FCAFC 134; 251 FCR 359 Baker v Carr (196......
-
Australian Financial Services and Leasing Pty Ltd v Hills Industries Ltd
...Australian law: Competition and Consumer Act 2010 (Cth), Sched 2 — Australian Consumer Law, ss 18, 20, 21, 22.See also Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (2013) 88 ALJR 261 at 270 [17]–[18] per French CJ, 283–284 [71]–[72] per Hayne J; 304 ALR 1 at 9–10, 27; [2013] HCA 50 i......
-
Alphapharm Pty Ltd v H Lundbeck A/S
...Act. See, generally, Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (2013) 88 ALJR 261 at 302–303 [186]–[193]; 304 ALR 1 at 51–53; [2013] HCA 50. 79 IPAC Report at 5 80 ‘Government Response to the Report of the Industrial Property Advisory Committee, “Patents, Innovation and Competition ......
Request a trial to view additional results
16 firm's commentaries
-
Isolated genetic material: invention or land grab? The D'Arcy v Myriad Genetics case
...in D'Arcy, above, n 9, at [158]. 28 Above, n 10,at [166]. 29 Patent number 686004 30 Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (2013) 304 ALR 1; 88 ALJR 261; [2013] HCA 50; BC201315312. 31 Above, n 10, at [206]. 32P Ng and W Liu "Raising the bar? The new patent law reforms and their......
-
High Court concludes that methods of medical treatment are patentable
...4 December 2013, the High Court judgment in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd & Ors [2013] HCA 50 was delivered. This is the first occasion the High Court has considered whether methods of medical treatment of the human body are patentable inventions within the meaning o......
-
Clinical Trial Disclosures A Significant Risk To Patent Validity In Australia
...Tyre & Rubber Co Ltd (1972) RPC 457 2 Also consistent with the High Court in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd & Ors [2013] HCA 50 3 See, e.g., Regeneron Pharmaceuticals Inc v Genentech Inc [2012] EWHC 657 (Pat); Hospira UK Limited v Genentech Inc [2015] EWHC 1796 (Pat); [20......
-
News from Abroad: High Court of Australia Hears Myriad Appeal
...Development Corporation v Commissioner of Patents (1959) 102 CLR 252; endorsed by the High Court in Apotex Pty Ltd v Sanofi Aventis [2013] HCA 50. 4 IPTA Submissions at [34]. 5 Attorney-General's Submissions at [6]. 6 Ibid at [10]. 7 Association for Molecular Pathology v Myriad Genetics 569......
Request a trial to view additional results
1 books & journal articles
-
International Ip Developments
...Office has enacted new provisions that permit patenting of methods of treatment. In Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50 (order), the High Court of Australia, Australia's Supreme Court, confirmed that methods of medical treatment are a "manner of manufacture" and ......